Received Jun 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9L944 | — |
Shingrix possible powder administration with another diluent than the one provided; Shingrix possible powder administration with another diluent than the one provided; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a elderly male patient who received Herpes zoster (Shingrix) (batch number 9L944, expiry date 30-MAR-2027) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: Shingrix possible powder administration with another diluent than the one provided) and inappropriate preparation of medication (Verbatim: Shingrix possible powder administration with another diluent than the one provided). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 13-JUN-2025 and 14-JUN-2025 Practice manager wanted to know how to proceed after finding a Shingrix box 2 with an odd number of vials only including the diluent, so she was supposing that the powder was administered to a patient using another diluent (saline water) than the one provided which led to Inappropriate dose of vaccine administered and Inappropriate preparation of medication. Also, mentioned that she still needed to find out who was the patient that received it. Recommendation was given about contacting the medical information team again if she finds out the patient involved and date of administration.